<DOC>
	<DOCNO>NCT00602355</DOCNO>
	<brief_summary>This study evaluate effectiveness antidepressant medication alone interpersonal psychotherapy alone treat woman postpartum depression .</brief_summary>
	<brief_title>Effectiveness Sertraline Alone Interpersonal Psychotherapy Alone Treating Women With Postpartum Depression</brief_title>
	<detailed_description>Postpartum depression ( PPD ) occur approximately 13 % postpartum woman . The impact PPD significant , include emotional distress woman well disturbances infant development . Common sign depression childbirth may include anxiety , irritability , low energy , lack concern self infant . If leave untreated , PPD may last 1 year , cause strain family life mother 's relationship infant . Infants depress mother also high risk developmental delay , behavioral problem , difficulty eat sleep . Despite public health significance PPD , relatively little research do determine effective treatment . Specifically , lack research concerning use antidepressant medication treat PPD . Interpersonal psychotherapy ( IPT ) , focus interpersonal issue relate depression , thoroughly study treatment PPD , compare treatment . This study evaluate effectiveness antidepressant medication alone IPT alone treat woman PPD . Participation double-blind study last 9 month . Participants first undergo initial assessment , include interview depressive symptom , self-report form medical history , blood test , pregnancy test . Participants randomly assign one three treatment : sertraline , placebo , IPT . All three treatment administer 13 week . Participants assign take sertraline placebo attend nine 30-minute session 13-week treatment period . During session , participant administer study medication assist parent issue skill psychiatrist . Participants receive IPT attend weekly 50-minute session 13-week treatment period . These session focus improve relationship others , set goal , increase cop skill . All participant also complete interview questionnaire depression month . Following 13 week treatment , participant undergo follow-up assessment Months 3 6 post-treatment . Follow-up assessment repeat initial interview questionnaire include form infant 's nature .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression , Postpartum</mesh_term>
	<mesh_term>Sertraline</mesh_term>
	<criteria>Primary DSMIV diagnosis major depressive disorder clinical interview Score great 12 HAMD Delivery infant within 12 month prior study entry Able speak read English sufficiently complete study procedure Willing use effective birth control method throughout study Woman whose infant die prior study entry Current past diagnosis bipolar disorder , schizophrenia psychotic disorder ; Diagnosis alcohol drug abuse dependence ( except nicotine ) anorexia past year ; Psychotic symptom ; Acute suicidal homicidal risk ; Women antidepressant 14 day prior consent , ( less 14 day willing taper , eligible continue taper ) ; Women daily anxiolytic medication ( i.e . benzodiazepine , buspirone ) daily psychoactive herbal preparation ( St. John 's Wort Fish Oil ) ( willing discontinue substance may eligible tapered ) ; Medications take PRN list dose frequency ( woman still eligible take : Lunesta/Eszopiclone 3 mg less , 3 night week , Ambien/Zolpidem 5mg less , Ambien CR 6.25 mg less , 3 night week , Lorazepam equivalent benzodiazepine dose : 0.5 mg 3 night week , Sonata/Zaleplon : 5 mg less , 3 night week , Rozerem/Ramelteon : 8 mg less , 3 night week ) ; If take antidepressant PRN insomnia ( eg : Desyrel/Trazodone , Elavil/Amitriptyline , Remeron/Mirtazapine ; Ongoing concurrent psychotherapeutic treatment psychotherapeutic treatment within last month ; Psychiatric symptom require specialized psychiatric treatment ; Significant medical disorder would make sertraline treatment contraindicate , Previous trial IPT therapy certify IPT therapist adequate trial sertraline ( i.e . least 8 week least 100 mg daily sertraline ) .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Postpartum</keyword>
	<keyword>Depression</keyword>
	<keyword>Medication Therapy</keyword>
	<keyword>Zoloft</keyword>
	<keyword>Sertraline</keyword>
	<keyword>Interpersonal Psychotherapy</keyword>
</DOC>